中红医疗
(300981)
| 流通市值：62.57亿 | | | 总市值：68.28亿 |
| 流通股本：3.93亿 | | | 总股本：4.29亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 1,478,364,167.05 | 601,919,053.24 | 2,373,206,803.4 | 1,863,658,896.34 |
| 营业总成本 | 1,338,013,799.24 | 610,659,330.18 | 2,451,906,534.08 | 1,889,367,380.39 |
| 其他经营收益 | | | | |
| 营业利润 | 181,952,282.83 | 7,105,966.75 | -125,528,884.39 | -10,434,972.84 |
| 利润总额 | 181,849,378.32 | 5,900,736.35 | -124,109,189.05 | -9,171,615.21 |
| 净利润 | 158,533,018.48 | 5,171,096.45 | -116,477,303.09 | -9,563,733.87 |
| 每股收益 | | | | |
| 其他综合收益 | -14,223,119 | -9,067,395.09 | -3,551,825.59 | -1,059,948.56 |
| 综合收益总额 | 144,309,899.48 | -3,896,298.64 | -120,029,128.68 | -10,623,682.43 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 5,196,371,384.1 | 5,144,249,431.79 | 4,728,554,393.32 | 4,858,841,151.02 |
| 非流动资产: | | | | |
| 非流动资产合计 | 2,491,865,029.94 | 2,646,740,887.91 | 2,709,243,705.19 | 2,793,238,146 |
| 资产总计 | 7,688,236,414.04 | 7,790,990,319.7 | 7,437,798,098.51 | 7,652,079,297.02 |
| 流动负债: | | | | |
| 流动负债合计 | 2,052,827,221.2 | 2,214,656,280.14 | 1,762,661,172.3 | 1,532,393,835.34 |
| 非流动负债: | | | | |
| 非流动负债合计 | 217,471,163.42 | 158,534,175.34 | 253,440,763.35 | 611,347,184.66 |
| 负债合计 | 2,270,298,384.62 | 2,373,190,455.48 | 2,016,101,935.65 | 2,143,741,020 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 5,257,728,920.07 | 5,257,946,900.21 | 5,260,709,320.4 | 5,368,713,903.59 |
| 股东权益合计 | 5,417,938,029.42 | 5,417,799,864.22 | 5,421,696,162.86 | 5,508,338,277.02 |
| 负债和股东权益合计 | 7,688,236,414.04 | 7,790,990,319.7 | 7,437,798,098.51 | 7,652,079,297.02 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 1,530,038,172.88 | 699,637,014.73 | 2,640,720,872.33 | 1,986,961,708.15 |
| 经营活动现金流出小计 | 1,319,016,191.63 | 641,162,126.46 | 2,636,985,188.2 | 2,077,628,083.36 |
| 经营活动产生的现金流量净额 | 211,021,981.25 | 58,474,888.27 | 3,735,684.13 | -90,666,375.21 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 8,174,852,194.68 | 1,663,513,687.9 | 7,570,113,798.54 | 4,877,338,484.37 |
| 投资活动现金流出小计 | 8,843,813,298.76 | 1,628,430,423.91 | 7,193,113,833.23 | 4,977,439,662.24 |
| 投资活动产生的现金流量净额 | -668,961,104.08 | 35,083,263.99 | 376,999,965.31 | -100,101,177.87 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 999,274,340.51 | 657,001,647.68 | 1,169,381,832.54 | 1,066,698,053.13 |
| 筹资活动现金流出小计 | 966,803,646.61 | 340,959,764.63 | 918,540,495.53 | 679,241,525.72 |
| 筹资活动产生的现金流量净额 | 32,470,693.9 | 316,041,883.05 | 250,841,337.01 | 387,456,527.41 |
| 汇率变动对现金及现金等价物的影响 | -5,102,019.71 | 1,276,862.77 | -20,975,645.27 | 8,688,992.34 |
| 现金及现金等价物净增加额 | -430,570,448.64 | 410,876,898.08 | 610,601,341.18 | 205,377,966.67 |
| 期末现金及现金等价物余额 | 756,983,623.86 | 1,598,430,970.58 | 1,187,554,072.5 | 782,330,697.99 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -430,570,448.64 | - | 610,601,341.18 | - |